The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmurfit Kappa Regulatory News (SKG)

Share Price Information for Smurfit Kappa (SKG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,490.00
Bid: 3,476.00
Ask: 3,478.00
Change: -10.00 (-0.29%)
Spread: 2.00 (0.058%)
Open: 3,516.00
High: 3,544.00
Low: 3,472.00
Prev. Close: 3,500.00
SKG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SMURFIT KAPPA GROUP PLC

2 May 2018 14:36

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

SMURFIT KAPPA GROUP PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

€0.001 ordinary shares

Date of dealing

1 May 2018

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: €0.001 ordinary shares
Long Short
Number (%) Number (%)
(1) Relevant securities
3,240,833 1.37% 739,317 0.31%
(2) Derivatives (other than options):
245,112 0.10% 1,844,241 0.78%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
(4) TOTAL:
3,485,945 1.47% 2,583,558 1.09%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase 28 31.0200 GBP
Purchase 73 31.0800 GBP
Purchase 93 31.0634 GBP
Purchase 195 35.4000 EUR
Purchase 305 35.4679 EUR
Purchase 483 35.5811 EUR
Purchase 1,040 35.5318 EUR
Purchase 2,578 34.9800 EUR
Purchase 3,269 30.9386 GBP
Purchase 4,019 30.9347 GBP
Purchase 4,219 30.9400 GBP
Purchase 4,222 35.0993 EUR
Purchase 11,072 30.9508 GBP
Sale 13 31.0600 GBP
Sale 101 31.0633 GBP
Sale 154 31.0868 GBP
Sale 218 31.3403 GBP
Sale 222 34.9060 EUR
Sale 445 31.0995 GBP
Sale 658 31.2665 GBP
Sale 2,426 34.9800 EUR
Sale 3,809 30.9287 GBP
Sale 11,089 31.0041 GBP
Sale 19,115 35.4580 EUR

(b) Derivatives transactions (other than options transactions)

Product Name Nature of transaction Number of relevant securities Price per
unit
€0.001 ordinary shares Long 100 34.9313 EUR
€0.001 ordinary shares Long 122 34.8717 EUR
€0.001 ordinary shares Long 154 31.0868 GBP
€0.001 ordinary shares Long 2,358 31.0623 GBP
€0.001 ordinary shares Long 2,875 30.9375 GBP
€0.001 ordinary shares Long 5,577 31.0110 GBP
€0.001 ordinary shares Long 19,115 35.4580 EUR
€0.001 ordinary shares Long 51,938 31.3300 GBP
€0.001 ordinary shares Short 195 35.4070 EUR
€0.001 ordinary shares Short 305 35.4679 EUR
€0.001 ordinary shares Short 1,040 35.5317 EUR
€0.001 ordinary shares Short 1,327 30.7432 GBP
€0.001 ordinary shares Short 2,578 34.9826 EUR
€0.001 ordinary shares Short 51,938 35.7200 EUR

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option

Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details Price per unit

(if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

2 May 2018

Contact name

Jay Supaya

Telephone number

020 7773 0635

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

View source version on businesswire.com: https://www.businesswire.com/news/home/20180502005895/en/

Copyright Business Wire 2018

Date   Source Headline
30th Jan 20243:35 pmRNSHolding(s) in Company
11th Jan 20249:48 amRNSHolding(s) in Company
5th Jan 20244:42 pmRNSHolding(s) in Company
2nd Jan 20242:02 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSHolding(s) in Company
2nd Jan 20247:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSHolding(s) in Company
21st Dec 20232:38 pmRNSHolding(s) in Company
19th Dec 20234:01 pmRNSHolding(s) in Company
14th Dec 202311:01 amRNSHolding(s) in Company
11th Dec 202311:17 amRNSHolding(s) in Company
8th Dec 20233:41 pmRNSHolding(s) in Company
7th Dec 202312:30 pmRNSHolding(s) in Company
6th Dec 20235:04 pmRNSHolding(s) in Company
6th Dec 202310:12 amRNSHolding(s) in Company
1st Dec 20234:11 pmRNSDirector/PDMR Shareholding
1st Dec 20232:34 pmRNSHolding(s) in Company
1st Dec 20239:59 amRNSHolding(s) in Company
28th Nov 20235:10 pmRNSHolding(s) in Company
27th Nov 202312:47 pmRNSHolding(s) in Company
24th Nov 202310:12 amRNSHolding(s) in Company
23rd Nov 20233:36 pmRNSHolding(s) in Company
22nd Nov 20235:28 pmRNSHolding(s) in Company
20th Nov 202312:41 pmRNSHolding(s) in Company
15th Nov 20233:50 pmRNSHolding(s) in Company
9th Nov 20234:20 pmRNSDirector/PDMR Shareholding
6th Nov 20239:50 amRNSHolding(s) in Company
3rd Nov 202310:27 amRNSHolding(s) in Company
1st Nov 20237:00 amBUSTrading Statement
31st Oct 202312:40 pmRNSHolding(s) in Company
30th Oct 20233:22 pmRNSHolding(s) in Company
27th Oct 20232:24 pmRNSHolding(s) in Company
26th Oct 202310:22 amRNSHolding(s) in Company
24th Oct 20235:25 pmRNSHolding(s) in Company
24th Oct 20239:32 amRNSHolding(s) in Company
23rd Oct 20231:59 pmRNSHolding(s) in Company
18th Oct 20238:31 amBUSNotice of Results
17th Oct 20237:00 amRNSHolding(s) in Company
13th Oct 20233:16 pmRNSHolding(s) in Company
12th Oct 20232:31 pmRNSHolding(s) in Company
11th Oct 202312:06 pmRNSHolding(s) in Company
9th Oct 20234:10 pmRNSHolding(s) in Company
27th Sep 20234:46 pmRNSDirector/PDMR Shareholding
25th Sep 20235:02 pmRNSDirector/PDMR Shareholding
21st Sep 20234:38 pmRNSHolding(s) in Company
18th Sep 20232:34 pmRNSHolding(s) in Company
13th Sep 20233:32 pmRNSDirector/PDMR Shareholding
13th Sep 202312:53 pmRNSHolding(s) in Company
12th Sep 20237:32 amBUSStatement re Smurfit Kappa and WestRock Announce Transaction to Create a Global Leader in Sustainable Packaging
7th Sep 20237:00 amBUSStatement re Smurfit Kappa and WestRock in discussions regarding key terms of Potential Combination

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.